In the first part of our study, we examined the expression levels of CDCA genes (CDCA2, CDCA3, CDCA4, CDCA5, CDCA7, and CDCA8) in 12 GBM and 6 normal control cell lines using RT-qPCR. The gene discussed is CDCA5; the disease is glioblastoma.